ReviewFrontiers in oncology2026

Advances and challenges in biomarker guided management of triple-negative breast cancer in the era of neoadjuvant chemo-immunotherapy.

Mariarosaria D'Amato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.